Literature DB >> 20679732

Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice.

Stephen T Reece1, Christoph Loddenkemper, David J Askew, Ulrike Zedler, Sandra Schommer-Leitner, Maik Stein, Fayaz Ahmad Mir, Anca Dorhoi, Hans-Joachim Mollenkopf, Gary A Silverman, Stefan H E Kaufmann.   

Abstract

The hallmark of human Mycobacterium tuberculosis infection is the presence of lung granulomas. Lung granulomas can have different phenotypes, with caseous necrosis and hypoxia present within these structures during active tuberculosis. Production of NO by the inducible host enzyme NOS2 is a key antimycobacterial defense mechanism that requires oxygen as a substrate; it is therefore likely to perform inefficiently in hypoxic regions of granulomas in which M. tuberculosis persists. Here we have used Nos2-/- mice to investigate host-protective mechanisms within hypoxic granulomas and identified a role for host serine proteases in hypoxic granulomas in determining outcome of disease. Nos2-/- mice reproduced human-like granulomas in the lung when infected with M. tuberculosis in the ear dermis. The granulomas were hypoxic and contained large amounts of the serine protease cathepsin G and clade B serine protease inhibitors (serpins). Extrinsic inhibition of serine protease activity in vivo resulted in distorted granuloma structure, extensive hypoxia, and increased bacterial growth in this model. These data suggest that serine protease activity acts as a protective mechanism within hypoxic regions of lung granulomas and present a potential new strategy for the treatment of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20679732      PMCID: PMC2929725          DOI: 10.1172/JCI42796

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Microbiology. An antibiotic mimics immunity.

Authors:  Carl Nathan
Journal:  Science       Date:  2008-11-28       Impact factor: 47.728

Review 2.  New insights into the function of granulomas in human tuberculosis.

Authors:  Timo Ulrichs; Stefan H E Kaufmann
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

3.  Ipr1 gene mediates innate immunity to tuberculosis.

Authors:  Hui Pan; Bo-Shiun Yan; Mauricio Rojas; Yuriy V Shebzukhov; Hongwei Zhou; Lester Kobzik; Darren E Higgins; Mark J Daly; Barry R Bloom; Igor Kramnik
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

4.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 5.  Neutrophil granule contents in the pathogenesis of lung injury.

Authors:  Theo J Moraes; Joanna H Zurawska; Gregory P Downey
Journal:  Curr Opin Hematol       Date:  2006-01       Impact factor: 3.284

6.  Downregulation of neutrophil CD43 by opsonized zymosan.

Authors:  E Remold-O'Donnell; D Parent
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

7.  Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

Authors:  R S Wallis; M S Broder; J Y Wong; M E Hanson; D O Beenhouwer
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

8.  Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity.

Authors:  E J Campbell; E K Silverman; M A Campbell
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

9.  Combination of host susceptibility and virulence of Mycobacterium tuberculosis determines dual role of nitric oxide in the protection and control of inflammation.

Authors:  Martin Beisiegel; Mischo Kursar; Markus Koch; Christoph Loddenkemper; Stefanie Kuhlmann; Ulrike Zedler; Manuela Stäber; Robert Hurwitz; Stefan H E Kaufmann
Journal:  J Infect Dis       Date:  2009-04-15       Impact factor: 5.226

10.  PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.

Authors:  Ramandeep Singh; Ujjini Manjunatha; Helena I M Boshoff; Young Hwan Ha; Pornwaratt Niyomrattanakit; Richard Ledwidge; Cynthia S Dowd; Ill Young Lee; Pilho Kim; Liang Zhang; Sunhee Kang; Thomas H Keller; Jan Jiricek; Clifton E Barry
Journal:  Science       Date:  2008-11-28       Impact factor: 63.714

View more
  48 in total

1.  Paucimannose-Rich N-glycosylation of Spatiotemporally Regulated Human Neutrophil Elastase Modulates Its Immune Functions.

Authors:  Ian Loke; Ole Østergaard; Niels H H Heegaard; Nicolle H Packer; Morten Thaysen-Andersen
Journal:  Mol Cell Proteomics       Date:  2017-06-19       Impact factor: 5.911

Review 2.  SERPINB3 and B4: From biochemistry to biology.

Authors:  Yu Sun; Namratha Sheshadri; Wei-Xing Zong
Journal:  Semin Cell Dev Biol       Date:  2016-09-13       Impact factor: 7.727

Review 3.  Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases.

Authors:  Colleen M McClean; David M Tobin
Journal:  Pathog Dis       Date:  2016-07-10       Impact factor: 3.166

Review 4.  Amino acid auxotrophy as a system of immunological control nodes.

Authors:  Peter J Murray
Journal:  Nat Immunol       Date:  2016-02       Impact factor: 25.606

Review 5.  Macrophage immunoregulatory pathways in tuberculosis.

Authors:  Murugesan V S Rajaram; Bin Ni; Claire E Dodd; Larry S Schlesinger
Journal:  Semin Immunol       Date:  2014-10-30       Impact factor: 11.130

6.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

Review 7.  Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.

Authors:  Joseph E Qualls; Peter J Murray
Journal:  Semin Immunopathol       Date:  2015-10-21       Impact factor: 9.623

8.  IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection.

Authors:  Joshua C Cyktor; Bridget Carruthers; Rachel A Kominsky; Gillian L Beamer; Paul Stromberg; Joanne Turner
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

Review 9.  A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.

Authors:  Véronique Dartois; Clifton E Barry
Journal:  Bioorg Med Chem Lett       Date:  2013-07-12       Impact factor: 2.823

10.  Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas.

Authors:  María A Duque-Correa; Anja A Kühl; Paulo C Rodriguez; Ulrike Zedler; Sandra Schommer-Leitner; Martin Rao; January Weiner; Robert Hurwitz; Joseph E Qualls; George A Kosmiadi; Peter J Murray; Stefan H E Kaufmann; Stephen T Reece
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.